|
Oropharyngeal Cancer Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 90 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Oropharyngeal Cancer Global Clinical Trials Review, H1, 2012" provides data on the Oropharyngeal Cancer clinical trial scenario. This report provides.....
Introduction GlobalData's clinical trial report, “Oropharyngeal Cancer Global Clinical Trials Review, H1, 2012" provides data on the Oropharyngeal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Oropharyngeal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Oropharyngeal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Oropharyngeal Cancer 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials by Country 8 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Clinical Trials by BRIC Nations 13 Clinical Trials by G7 Nations 14 Clinical Trials in G7 Nations by Trial Status 15 Clinical Trials by E7 Nations 16 Clinical Trials in E7 Nations by Trial Status 17 Clinical Trials by Phase 18 In Progress Trials by Phase 19 Clinical Trials by Trial Status 20 Unaccomplished Trials of Oropharyngeal Cancer 21 Subjects Recruited Over a Period of Time 23 Prominent Sponsors 24 Top Companies Participating in Oropharyngeal Cancer Therapeutics Clinical Trials 26 Prominent Drug Comparison 27 Clinical Trial Profiles 28 Clinical Trial Overview of Top Companies 28 Endo Pharmaceuticals Inc. 28 Clinical Trial Overview of Endo Pharmaceuticals Inc. 28 Pharmacyclics, Inc. 29 Clinical Trial Overview of Pharmacyclics, Inc. 29 Vical Incorporated 30 Clinical Trial Overview of Vical Incorporated 30 Clinical Trial Overview of Top Universities / Institutes / Hospitals 31 The University of Texas M. D. Anderson Cancer Center 31 Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 31 Ohio State University Comprehensive Cancer Center 32 Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 32 Stanford University 33 Clinical Trial Overview of Stanford University 33 Radiation Therapy Oncology Group 34 Clinical Trial Overview of Radiation Therapy Oncology Group 34 Mount Sinai School of Medicine 35 Clinical Trial Overview of Mount Sinai School of Medicine 35 Shanghai Jiao Tong University 36 Clinical Trial Overview of Shanghai Jiao Tong University 36 Southeastern Medical Oncology Center 37 Clinical Trial Overview of Southeastern Medical Oncology Center 37 Institut Gustave Roussy 38 Clinical Trial Overview of Institut Gustave Roussy 38 Abramson Cancer Center 39 Clinical Trial Overview of Abramson Cancer Center 39 European Organization for Research and Treatment of Cancer 40 Clinical Trial Overview of European Organization for Research and Treatment of Cancer 40 Southwest Oncology Group 41 Clinical Trial Overview of Southwest Oncology Group 41 Groupe Oncologie Radiotherapie Tete et Cou 42 Clinical Trial Overview of Groupe Oncologie Radiotherapie Tete et Cou 42 Johannes Gutenberg University Mainz 43 Clinical Trial Overview of Johannes Gutenberg University Mainz 43 Wake Forest University 44 Clinical Trial Overview of Wake Forest University 44 FUDAN University 45 Clinical Trial Overview of FUDAN University 45 University of Zurich 46 Clinical Trial Overview of University of Zurich 46 VCU Massey Cancer Center 47 Clinical Trial Overview of VCU Massey Cancer Center 47 Samsung Medical Center 48 Clinical Trial Overview of Samsung Medical Center 48 University of Michigan Comprehensive Cancer Center 49 Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 49 Roswell Park Cancer Institute 50 Clinical Trial Overview of Roswell Park Cancer Institute 50 Five Key Clinical Profiles 51 Appendix 87 Abbreviations 87 Definitions 87 Research Methodology 88 Secondary Research 88 About GlobalData 89 Contact Us 89 Disclaimer 89 Source 90 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7 Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 Oropharyngeal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 10 Oropharyngeal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11 Oropharyngeal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 12 Oropharyngeal Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 13 Oropharyngeal Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 14 Oropharyngeal Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15 Oropharyngeal Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 16 Oropharyngeal Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 17 Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 18 Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 19 Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 20 Oropharyngeal Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 21 Oropharyngeal Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 22 Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 23 Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25 Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26 Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 27 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo Pharmaceuticals Inc., 2012* 28 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2012* 29 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vical Incorporated, 2012* 30 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 31 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2012* 32 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 33 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2012* 34 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai School of Medicine, 2012* 35 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Jiao Tong University, 2012* 36 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeastern Medical Oncology Center, 2012* 37 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Gustave Roussy, 2012* 38 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012* 39 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012* 40 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2012* 41 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe Oncologie Radiotherapie Tete et Cou, 2012* 42 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johannes Gutenberg University Mainz, 2012* 43 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 44 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012* 45 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2012* 46 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by VCU Massey Cancer Center, 2012* 47 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012* 48 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012* 49 Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 50 List of Figures Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7 Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 Oropharyngeal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 10 Oropharyngeal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11 Oropharyngeal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12 Oropharyngeal Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 13 Oropharyngeal Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 14 Oropharyngeal Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15 Oropharyngeal Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 16 Oropharyngeal Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 17 Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 18 Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 19 Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 20 Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 23 Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24 Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26 Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 27 GlobalData Methodology 88 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
